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Abstract: The NMDA receptor is a major target of alcohol action in the CNS, 
and recent behavioral and cellular studies have pointed to the importance of 
the GluN2B subunit in alcohol action. We and others have previously 
characterized four amino acid positions in the third and fourth membrane-
associated (M) domains of the NMDA receptor GluN2A subunit that influence 
both ion channel gating and alcohol sensitivity. In this study, we found that 
substitution mutations at two of the four corresponding positions in the 
GluN2B subunit, F637 and G826, influence ethanol sensitivity and ion channel 
gating. Because position 826 contains a glycine residue in the native protein, 
we focused our attention on GluN2B(F637). Substitution mutations at 
GluN2B(F637) significantly altered ethanol IC50 values, glutamate EC50 values 
for peak (Ip) and steady-state (Iss) current, and steady-state to peak current 
ratios (Iss:Ip). Changes in apparent glutamate affinity were not due to agonist 
trapping in desensitized states, as glutamate Iss EC50 values were not 
correlated with Iss:Ip values. Ethanol sensitivity was correlated with values of 
both Ip and Iss glutamate EC50, but not with Iss:Ip. Values of ethanol IC50, 
glutamate EC50, and Iss:Ip for mutants at GluN2B(F637) were highly correlated 
with the corresponding values for mutants at GluN2A(F636), consistent with 
similar functional roles of this position in both subunits. These results 
demonstrate that GluN2B(Phe637) regulates ethanol action and ion channel 
function of NMDA receptors. However, despite highly conserved M domain 
sequences, ethanol's actions on GluN2A and GluN2B subunits differ. 
Keywords: Alcohol, Ethanol, Glutamate, NMDA receptors 
1. Introduction 
Alcohol addiction, characterized by uncontrolled consumption of 
alcoholic beverages despite the negative consequences, is thought to 
be associated with disorganized motor function, cognition, and 
aberrant learning and memory processes (Koob, 2003 and Weiss and 
Porrino, 2002), all of which involve NMDA receptors. Following the 
initial findings that alcohol inhibits the NMDA receptor (Hoffman et al., 
1989, Lima-Landman and Albuquerque, 1989 and Lovinger et al., 
1989), a large number of studies have established that the NMDA 
receptor is a major target of alcohol action in the brain that plays a 
role in several ethanol-associated phenomena such as craving, 
tolerance, dependence, withdrawal, and relapse (Chandrasekar, 2013, 
Gass and Olive, 2008, Holmes et al., 2013, Krishnan-Sarin et al., 
2015, Krupitsky et al., 2007, Krystal et al., 2003, Vengeliene et al., 
2005, Vengeliene et al., 2008 and Woodward, 1999). Alcohol inhibits 
NMDA receptors by altering ion channel gating, specifically by 
decreasing channel opening frequency and mean open time (Lima-
Landman and Albuquerque, 1989 and Wright et al., 1996), but does so 
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via an interaction with a novel modulatory site (Chu et al., 1995, 
Gonzales and Woodward, 1990, Göthert and Fink, 1989 and Peoples 
and Weight, 1992). The NMDA receptor is a heterotetramer formed 
from two obligatory GluN1 subunits and two GluN2 subunits, of which 
four different isoforms are expressed in the brain (GluN2A-GluN2D; 
(Dingledine et al., 1999)). Previous studies in our and other 
laboratories have identified and characterized a number of ethanol-
sensitive positions in the M3 and M4 domain of the GluN1 and GluN2A 
subunit (Honse et al., 2004, Ren et al., 2003a, Ren et al., 2003b, Ren 
et al., 2007, Ren et al., 2012, Ren et al., 2013, Ronald et al., 2001, 
Smothers and Woodward, 2006 and Xu et al., 2012). Although the 
GluN2A subunit-containing NMDA receptor predominates in the 
mammalian brain, the GluN2B subunit has comparable ethanol 
sensitivity (Allgaier, 2002, Kuner et al., 1993, Masood et al., 1994, 
Popp et al., 1998 and Smothers et al., 2001) and plays an important 
role in alcohol action (Boyce-Rustay and Holmes, 2005, Izumi et al., 
2005, Kash et al., 2008, Kash et al., 2009, Nagy, 2004, Wang et al., 
2007 and Wills and Winder, 2013). However, the identity of ethanol-
sensitive positions in the GluN2B subunit, and whether these are 
important for ion channel gating, is unknown. Because the M3 and M4 
domain sequences of the GluN2A and GluN2B subunit are highly 
homologous, we tested whether positions in the GluN2B M domains 
corresponding to ethanol-sensitive positions in the GluN2A subunit 
regulate GluN2B subunit ethanol sensitivity. Despite the high 
homology between the GluN2A and GluN2B subunit M domains, we 
found that mutations at only two of four cognate positions altered 
alcohol sensitivity in the GluN2B subunit, and one of these is occupied 
by a glycine residue in the native protein. Although ethanol may 
interact with main chain carbonyl groups at positions containing 
glycine residues (Dwyer, 1999), such as 826, substitution of the 
glycine at this position could disrupt functional aspects of the alpha-
helix. Although the characteristics of the remaining position, F637, 
were highly analogous to those of its cognate position in the GluN2A 
subunit, the differences at the other positions suggest that there are 
important differences in the action of ethanol on the GluN2A and 
GluN2B subunits. 
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2. Materials and methods 
Chemicals. Ethanol (95%, prepared from grain) was obtained 
from Pharmco-Aaper (Brookfield, CT) and all other chemicals were 
obtained from Sigma–Aldrich Chemical Co. (St. Louis, MO, USA). 
Chemicals used to make recording solutions were the highest purity 
available. 
Site-directed mutagenesis, cell culture and transfection. Site-
directed mutagenesis in plasmids containing GluN2B subunit cDNA was 
performed using the QuickChange kit (Stratagene La Jolla, CA, USA), 
and all mutations were verified by DNA sequencing. Transformed 
human embryonic kidney (tsA 201) cells were seeded in 35-mm poly-
d-lysine coated dishes, and cultured in minimum essential medium 
(MEM) containing 10% heat-inactivated fetal bovine serum to 70–95% 
confluence. Cells were then transfected with cDNA for the GluN1-1a, 
wild type or mutant GluN2B subunits and green fluorescent protein 
(pGreen Lantern; Invitrogen, Carlsbad, CA) at a 2:2:1 ratio using 
calcium phosphate transfection kit (Invitrogen). After transfection, 
200 μM dl-2-amino-5-phosphonovaleric acid (APV) and 100 μM 
ketamine were added into culture medium to protect cells from 
receptor-mediated excitotoxicity. Cells were recorded within 48 h 
following transfection. Antagonists were removed before recording by 
extensive washing. 
Electrophysiological recording. Whole-cell patch-clamp 
recordings were performed at room temperature using an Axopatch 1D 
or 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Gigaohm 
seals were formed in whole-cell recording using patch pipettes with tip 
resistances of 2–4 MΩ, and series resistances of 1–5 MΩ were 
compensated by 80%. Cells were voltage-clamped at −50 mV and 
superfused in an external recording solution containing (in mM): NaCl, 
150; KCl, 5; CaCl2, 0.2; HEPES, 10; glucose, 10; and sucrose, 10; 
osmolality was adjusted to 340 mmol/kg with sucrose. The ratio of 
added HEPES free acid and sodium salt was calculated to result in a 
solution pH of 7.4 (Buffer Calculator, R. Beynon, University of 
Liverpool); final pH was adjusted, if necessary, using HCl or NaOH. 
Low Ca2+ was used to minimize NMDA receptor inactivation, and EDTA, 
10 μM, was added to the recording solution to eliminate the fast 
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component of apparent desensitization due to high-affinity Zn2+ 
inhibition ( Low et al., 2000, Ren et al., 2003b and Erreger and 
Traynelis, 2005). Recording solutions were prepared fresh daily and 
applied to cells using a stepper motor-driven solution exchange 
apparatus (Warner Instruments, Hamden, CT, USA) and three-barrel 
square glass tubing of internal diameter 600 μm. The intracellular 
recording solution (patch-pipette) contained (in mM) CsCl, 140; 
Mg4ATP, 2; BAPTA, 10; and HEPES, 10 (pH 7.2). In order to increase 
the speed of the solution exchange in glutamate concentration-
response experiments, cells were lifted off the surface of the dish after 
gaining a gigaohm seal. Data were filtered at 2 kHz (8-pole Bessel) 
and acquired at 5 kHz on a computer using a DigiData interface and 
pClamp software (Molecular Devices). 
Calculation of physicochemical properties of amino acids. 
Molecular (Van der Waals) volumes of amino acids were calculated 
using Spartan Pro (Wavefunction, Inc., Irvine, CA) following structural 
optimization using the AM1 semi-empirical parameters. Values used 
for amino acid hydropathy, hydrophilicity, and polarity were reported 
previously ( Ren et al., 2003b). 
Molecular modeling. Molecular modeling was performed on a 
Dell T3500 workstation with Discovery Studio 3.1 software (Accelrys, 
now Biovia; San Diego, CA). A model of a truncated version of the 
NMDA receptor was built based on the crystal structure of the rat 
NMDA heterotetramer that included both the ligand-binding and 
channel domains ( Karakas and Furukawa, 2014). We constructed a 
model confined to the channel structure of the protein and excluded 
the ligand-binding domain. The 4PE5 PDB file was used as a source of 
atomic coordinates and the sequences of rat GluNR1 and GluNR2B or 
GluNR2A subunits were aligned to the 4PE5 sequence. The original 
crystal structure lacks a number of key loops or segments, so these 
were built in piecemeal fashion using insert loop commands and, in 
some cases, by grafting a desired loop or segment to a new location. A 
model with the GluNR2B subunit was constructed first, and the version 
of the tetramer with the GluNR2A subunit was created from this model 
by mutating individual amino acids that differ in the two sequences. 
The structures were subjected to the same limited energy minimization 
regimen to resolve any major steric bumps. 
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Data analysis. In concentration-response experiments, IC50 or 
EC50 and n (slope factor) were calculated using the equation: 
y = Emax/1 + (IC50 or EC50/x)n, where y is the percent inhibition (for 
IC50) or the measured current amplitude (for EC50), x is concentration, 
and Emax is the maximal current amplitude. Statistical differences 
among concentration-response curves were determined by comparing 
log-transformed IC50 or EC50 values from fits to data obtained from 
individual cells using one-way analysis of variance (ANOVA) followed 
by the Dunnett test. Linear relations of mean values of log IC50, log 
EC50, or maximal steady-state to peak current ratio (ISS:IP) for the 
various mutants in GluN2A and GluN2B subunit were made using 
linear regression analysis. Values of log IC50, log EC50, and maximal 
steady-state to peak current ratio (ISS:IP) for GluN2A mutants are from 
previous studies ( Ren et al., 2003a, Ren et al., 2007, Ren et al., 
2013 and Honse et al., 2004). Time constants (τ) of deactivation were 
determined from fits of the current decay following the removal of 
glutamate (in the continued presence of glycine) to an exponential 
function using Clampfit (Axon Instruments). In most cells, deactivation 
was best fitted using a bi-exponential function; in these cases, the 
weighted time constant is reported. For cells in which deactivation was 
adequately fitted by a single exponential function, this value is 
reported. All values are reported as the mean ± SE. 
3. Results 
3.1. Effects of mutations at positions in GluN2B subunit 
M domains corresponding to alcohol-sensitive positions 
in GluN2A subunits 
The M3 and M4 domains are highly conserved among GluN1, 
GluN2A and GluN2B subunits (Fig. 1A). Previous studies from this 
laboratory have identified and characterized a number of ethanol-
sensitive positions in these domains of the GluN2A subunit (Fig. 1B) 
(Honse et al., 2004, Ren et al., 2003b, Ren et al., 2007 and Ren et al., 
2013). In this study, we initially constructed tryptophan and alanine 
substitutions at positions that correspond to ethanol-sensitive residues 
in the GluN2A subunit: Phe637, Phe638, Met824, and Gly826. 
Concentration-response experiments for ethanol inhibition showed that 
tryptophan or alanine mutations at Phe637 significantly changed 
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ethanol IC50 compared with the wild-type receptor, but that neither 
substitution altered ethanol sensitivity at F638 or M824. Tryptophan 
mutagenesis at GluN2B(Gly826) exhibited significantly decreased 
ethanol sensitivity compared with the wild-type receptor (Fig. 2A–B; 
ANOVA and Dunnett's test; p < 0.01 or p < 0.05). The effects of these 
substitutions in GluN2B on alcohol sensitivity thus substantially differ 
from the corresponding mutations in the GluN2A subunit ( Fig. 2C–D). 
Because the native residue at position 826 is glycine, and thus lacks a 
side chain, we chose to focus our investigation on GluN2B(F637). In 
order to study the role of GluN2B(Phe637) on ethanol action in detail, 
we made a panel of mutants at this position and tested ethanol 
sensitivities using whole-cell patch-clamp recording. All mutants we 
constructed yielded functional receptors that were inhibited by ethanol 
in a concentration-dependent manner (Fig. 3). Concentration-response 
curves for ethanol inhibition were essentially parallel to each other, as 
their slope factors did not differ significantly. 
 
Fig. 1. Positions in the GluN2B subunit M3 and M4 domains corresponding to alcohol-
sensitive positions in the GluN2A subunit. A. Partial sequences of the M3 and M4 
domains in GluN2A and GluN2B subunits. Ethanol-sensitive positions in GluN2A and 
their cognate positions in GluN2B are indicated in bold. GluN2B(Phe637) is underlined. 
B. Topological model of the GluN2B subunit showing the amino-terminal domain 
(ATD), ligand binding domain (LBD) composed of lobes S1–S2, and membrane-
associated domains (M1-M4) with the residues corresponding to the alcohol-sensitive 
positions in GluN2A shown as spheres. 
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Fig. 2. Ethanol sensitivity of tryptophan and alanine substitution mutations at GluN2B 
M3 and M4 residues corresponding to GluN2A ethanol-sensitive positions. A. 
Concentration-response curves show ethanol inhibition of glutamate–activated 
currents in the presence of 50 μM glycine in cells expressing either wild-type GluN1 
and GluN2B subunits or wild-type GluN1 and GluN2B tryptophan mutants at Phe637, 
Phe638, Met824, or Gly826. One-letter amino acid codes are used. Error bars are not 
shown to increase clarity. Curves shown are the best fits to the equation given under 
“ Materials and methods”. The curve for the wild-type receptor is shown as a dashed 
line. B. Bar graphs show average IC50 values for ethanol inhibition of glutamate-
activated current in the presence of 50 μM glycine in cells expressing wild-type GluN2B 
or GluN2B mutant subunits. IC50 values that are significantly different from the wild-
type receptor are indicated by asterisks (*P < 0.05; **P < 0.01; ANOVA and 
Dunnett's test). Results are means ± S.E of 5–7 cells. C. The M3 and M4 domains 
showing the approximate locations of the five positions tested. D. Comparison of 
ethanol IC50 values of various alanine or tryptophan mutants to the wild-type value. 
The x-axis shows the ethanol IC50 values of GluN2A subunit alanine (black circles) and 
tryptophan (black squares) substitutions and GluN2B subunit alanine (gray circles) and 
tryptophan (gray squares) substitutions at these positions. Ethanol IC50 values of wild-
type GluN2A-containing NMDA receptors (black dotted line) and GluN2B-containing 
NMDA receptors (gray dotted line) are shown. Ethanol IC50 values for alanine and 
tryptophan substitutions at various positions in GluN2A subunit are from ( Honse 
et al., 2004, Ren et al., 2003b, Ren et al., 2007 and Ren et al., 2013). 
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Fig. 3. Mutations at GluN2B(Phe637) alter ethanol sensitivity. A. Traces show currents 
activated by 10 μM glutamate in the presence of 50 μM glycine and their inhibition by 
100 mM ethanol in cells expressing the GluN1 subunit with either wild-type GluN2B 
subunits or various GluN2B(Phe637) mutant subunits. One-letter amino acid codes are 
used. B. Concentration-response curves for ethanol inhibition of glutamate-activated 
currents in the presence of 50 μM glycine in cells expressing various substitution 
mutations at GluN2B(Phe637). Results are the means ± S.E of 5–7 cells. Error bars 
are not shown to increase clarity. The dashed line shows the fit for the wild-type 
receptor. All curves are best fits to the equation given under “ Materials and methods”. 
C. Average IC50 values for ethanol inhibition of glutamate-activated current in wild-
type or GluN2B(Phe637) mutant receptors. Asterisks indicate significant differences 
from the IC50 value of the wild-type receptor (*P < 0.05; **P < 0.01; ANOVA and 
Dunnett's test). Results are the means ± S.E of 5–7 cells. 
Six out of ten substitution mutants at GluN2B(Phe637) showed 
significantly decreased ethanol sensitivity compared to the wild-type 
(WT) receptor (ANOVA; p < 0.05 or p < 0.01), however, none of the 
mutants exhibited increased ethanol sensitivity. Interestingly, although 
isoleucine and leucine are isomeric amino acids, ethanol sensitivity 
was significantly changed by substitution of isoleucine (IC50 value: 
307 ± 9.41 mM; ANOVA and Dunnett's test; p < 0.01), but not leucine 
(IC50 value: 150 ± 1.32 mM; ANOVA and Dunnett's test; p > 0.05). 
3.2. Mutations at GluN2B(Phe637) of NMDA receptor 
alter NMDA receptor function 
Previous studies showed that ethanol inhibits NMDA receptors 
by altering ion channel gating, primarily by decreasing mean open 
time of the channel, and studies from our laboratory reported that 
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mutations at ethanol-sensitive positions in the GluN2A subunit also 
strongly influence ion channel gating kinetics (Ren et al., 2003a, Ren 
et al., 2007, Ren et al., 2008, Ren et al., 2013 and Honse et al., 
2004). In this study, we first compared glutamate peak and steady-
state EC50 values between GluN2B wild-type and GluN2B(F637W) 
mutant subunits. The GluN2B(F637W) mutant showed significantly 
decreased glutamate EC50 values for peak (1.1 ± 0.17 μM; ANOVA and 
Dunnett's test; p < 0.01) and steady-state current (1.05 ± 0.16 μM; 
ANOVA and Dunnett's test; p < 0.01; Fig. 4A and B). In addition, the 
mutant receptor also showed significantly decreased apparent 
desensitization, as indicated by the Iss:Ip ratio for 300 μM glutamate-
activated current (Fig. 4C; ANOVA and Dunnett's test; p < 0.01), and 
an increased time constant of deactivation (τ) following removal of 
agonist (F637W: 2170 ± 2.84 ms; WT: 920 ± 3.30 ms; ANOVA; 
p < 0.0001; Fig. 4D). To further determine whether mutations at 
GluN2B(Phe637) can influence NMDA receptor characteristics, we 
performed glutamate concentration-response experiments on all 
mutants tested for ethanol sensitivity (Fig. 5). Seven out of ten 
mutants showed significantly decreased glutamate Ip EC50 values 
(ANOVA and Dunnett's test; p < 0.01; Fig. 6A), but only five mutants 
showed decreased glutamate Iss EC50 values (ANOVA and Dunnett's 
test; p < 0.01; Fig. 6B). Interestingly, there was again a difference 
between the isoleucine and leucine mutants, in that isoleucine 
substitution significantly altered glutamate Iss EC50 (0.85 ± 0.078 μM; 
ANOVA and Dunnett's test; p < 0.01), whereas leucine substitution did 
not (2.5 ± 0.24 μM; ANOVA and Dunnett's test; p > 0.05; Fig. 6B). 
Pronounced increases were observed for maximal Iss:Ip ratios in all 
mutants (ANOVA and Dunnett's test; p < 0.01; Fig. 6C). 
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Fig. 4. Tryptophan substitution at GluN2B(Phe637) alters glutamate potency, 
desensitization, and deactivation. A. Glutamate concentration-response curves for 
glutamate-activated peak and steady-state currents in the presence of 50 μM glycine 
in lifted cells expressing GluN1/GluN2B or GluN1/GluN2B(F637W) receptors. Data 
points are the means ± S.E of 6 cells. Error bars are not shown to increase clarity. 
Curves shown are best fits to the equation in “ Materials and methods” for peak 
(black) and steady-state (gray) currents. B. Average peak (open bars) and steady-
state (cross-hatched bars) current EC50 values recorded in lifted cells expressing either 
wild-type GluN1/GluN2B receptors or GluN1/GluN2B(F637W) receptors. Values that 
differed significantly from wild-type peak and steady-state current EC50 values are 
indicated by asterisks (**P < 0.01; ANOVA and Dunnett's test). Results are the 
means ± S.E of 6 cells. C. Normalized traces show the desensitization of 300 μM 
glutamate-activated current in the presence of 50 μM glycine in lifted cells expressing 
either wild-type GluN1/GluN2B or GluN1/GluN2B(F637W) receptors. D. Normalized 
traces show the difference in the deactivation of glutamate-activated current following 
removal of glutamate in lifted cells expressing either wild-type GluN1/GluN2B or 
GluN1/GluN2B(F637W) subunits. 
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Fig. 5. Mutations at GluN2B(Phe637) alter glutamate EC50.A. Traces show 300 μM 
glutamate-activated current in the presence of 50 μM glycine in lifted cells expressing 
wild-type receptors or receptors containing various substitutions at GluN2B(Phe637). 
One-letter amino acid codes are used. B–C. Concentration-response curves for 
glutamate-activated peak (B) and steady-state (C) current recorded from lifted cells 
expressing wild-type or mutant receptors. Results are the means ± S.E of 4–6 cells. 
Error bars are not shown to increase clarity. All curves shown are best fits to the 
equation described in “ Materials and methods”. The dashed curves indicate the fits for 
the wild-type receptor. 
 
 
Fig. 6. Mutations at GluN2B(Phe637) change glutamate potency. Bar graphs show the 
average EC50 values for glutamate-activated peak (A) and steady-state (B) currents 
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recorded from cells expressing GluN1 and wild-type GluN2B or GluN2B(Phe637) 
mutant subunits. Asterisks indicate EC50 values that differ significantly from that of the 
wild-type GluN1/GluN2B subunit (**P < 0.01; ANOVA and Dunnett's test). Results are 
the means ± S.E of 4–6 cells. C. The average values of maximal steady-state to peak 
current ratio (Iss:Ip) in lifted cells co-expressing GluN1 and GluN2B wild-type subunits 
or GluN2B subunits containing various substitutions at F637. Currents were activated 
by 300 μM glutamate in the presence of 50 μM glycine. Asterisks indicate Iss:Ip values 
that are significantly different from the value for the wild-type GluN1/GluN2B subunit 
(**P < 0.01; ANOVA and Dunnett's test). Results are the means ± S.E of 4–6 cells. 
Figure options 
3.3. Relation of GluN2B(Phe637) mutant peak current 
glutamate EC50, steady-state EC50, and maximal 
steady-state to peak current ratio 
For a series of mutants at GluN2A(F636), glutamate EC50 values 
for steady-state current were highly correlated with those for peak 
current, but not with values of Iss:Ip (Ren et al., 2013). In the present 
study, we observed that peak current glutamate EC50 values were 
strongly correlated with steady-state current glutamate EC50 values 
(R2 = 0.95, P < 0.0001; Fig. 7A). However, EC50 values for glutamate-
activated steady-state current for mutants at GluN2B(F637) were not 
significantly correlated with maximal Iss:Ip values (R2 = 0.014, 
P > 0.05; Fig. 7B). 
 
Fig. 7. Correlations among glutamate peak and steady-state current EC50 ethanol IC50 
values. A. Graph plots values of glutamate log EC50 for steady-state current versus 
peak current in a series of mutants. Glutamate EC50 values for peak and steady-state 
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current were significantly correlated (R2 = 0.95, P < 0.0001). The lines shown are the 
least squares fits to the data. B. Graph plots log maximal steady-state to peak current 
ratio (Iss:Ip) versus either glutamate peak current log EC50 values or glutamate steady-
state current log EC50 values for various GluN1/GluN2B(Phe637) mutant receptors. Log 
maximal Iss:Ip for glutamate was not correlated with either peak or steady-state 
glutamate EC50 (p > 0.05). The lines shown are the least squares fits to the data. C–D. 
Graphs plot log ethanol IC50 values in a series of mutants versus log values of 
glutamate EC50 for peak or steady-state current (C) or the maximal Iss:Ip values (D). 
Ethanol IC50 values were correlated with glutamate EC50 for peak (R2 = 0.75, 
p < 0.001) and steady-state current (R2 = 0.59, p < 0.005), but not with Iss:Ip values 
(R2 = 0.19, p > 0.05). The lines shown are the least squares fits to the data. 
3.4. Determinants of ethanol sensitivity and receptor 
function among mutants at GluN2B(Phe637) 
To determine the manner in which the physical–chemical 
properties of the substituent at GluN2B(F637) contribute to the 
changes in ethanol IC50 values, glutamate EC50 values, and Iss:Ip 
values, we tested for linear relations of these values to amino acid 
polarity, hydrophilicity, and molecular volume. However, no significant 
linear relations were detected among these measures (Table 1). 
Table 1. Relation of NMDA receptor agonist potency and ethanol sensitivity to the 
physicochemical parameters of the substituent at GluN2B(Phe637). 
 
Glutamate Ip EC50 
 
Ethanol IC50 
 
R2 P value R2 P value 
Molecular volume 0.107 >0.05 0.073 >0.05 
Hydrophilicity 0.081 >0.05 0.109 >0.05 
Polarity 0.022 >0.05 0.034 >0.05 
Because substitution mutations at GluN2B(Phe637) altered both 
ethanol sensitivity and NMDA receptor function, we asked whether the 
observed changes in ethanol sensitivity among the series of mutant 
subunits might have resulted from changes in agonist potency or ion 
channel gating kinetics. Plots of ethanol IC50 values against values of 
glutamate EC50 for peak current, steady-state current, or maximal 
Iss:Ip revealed that ethanol sensitivity of mutants was significantly 
negatively correlated with both peak (R2 = 0.75, p < 0.001; Fig. 7C) 
and steady-state (R2 = 0.59, p < 0.005) current EC50 values, but was 
not correlated with maximal Iss:Ip (p > 0.05; Fig. 7D). 
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3.5. Effects of mutations at GluN2B(Phe637) and 
GluN2A(Phe636) on ethanol sensitivity and ion channel 
function are similar 
Because mutations at GluN2B(Phe637) and at its cognate 
position, GluN2A(Phe636), can both alter ethanol sensitivity and ion 
channel function (Ren et al., 2013), we evaluated whether the side 
chain at this position regulates the ion channel in a similar manner in 
the two subunits. We thus tested for correlations among mutants at 
GluN2B(Phe637) and GluN2A(F636) for glutamate Ip and Iss EC50, 
maximal Iss:Ip, and ethanol IC50 values. For the two series of mutants 
at GluN2B(F637) and GluN2A(F636), we observed significant 
correlations for values of glutamate EC50 for peak (R2 = 0.84, 
p < 0.0001; Fig. 8A) and steady-state (R2 = 0.76, p < 0.001; Fig. 8B) 
current, maximal Iss:Ip (R2 = 0.49, p < 0.05; Fig. 8C), and ethanol IC50 
(R2 = 0.95, p < 0.0001; Fig. 8D). 
 
Fig. 8. Ethanol sensitivity and glutamate EC50 values of GluN2B(Phe637) mutants are 
correlated with these parameters in GluN2A(Phe636) mutants. A–B. Graphs plot log 
values of either Ip EC50 (A) or Iss EC50 (B) for GluN2B(Phe637) mutants versus each of 
these two parameters for GluN2A(Phe636) mutants. Both peak and steady-state 
glutamate EC50 values were significantly correlated in the two subunit types 
(R2 = 0.84, P < 0.0001 and R2 = 0.76, P < 0.001, respectively). The lines shown are 
the least squares fits to the data. C. Values of maximal steady-state to peak current 
ratio (Iss:Ip) of GluN2B(Phe637) and GluN2A(Phe636) mutant receptors were 
significantly correlated (R2 = 0.49, P < 0.05). The line shown is the least squares fits 
to the data. D, Log ethanol IC50 values for mutants at GluN2B(Phe637) and 
GluN2A(Phe636) were significantly correlated (R2 = 0.95, P < 0.0001). The line shown 
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is the least squares fit to the data. Ethanol IC50 values, glutamate EC50 values, and 
maximal Iss:Ip values of GluN2A(Phe636) mutants are from a previous study in this 
laboratory (Ren et al., 2013). 
4. Discussion 
We and others have used alanine- and tryptophan-scanning to 
identify alcohol-sensitive positions in the GluN1 and GluN2A subunits 
(Ren et al., 2003b, Ren et al., 2007, Ren et al., 2012, Ronald et al., 
2001, Salous et al., 2009 and Smothers and Woodward, 2006). 
Previous studies in this laboratory identified several ethanol-sensitive 
positions in both the M3 and M4 domains of the GluN2A subunit: 
Phe636, Phe637, Met823, and Ala825 (Honse et al., 2004, Ren et al., 
2003b, Ren et al., 2007 and Ren et al., 2013). In the present study, 
alanine and tryptophan substitutions were initially introduced into the 
cognate positions in the GluN2B subunit M3 and M4 domains, which 
are Phe637, Phe638, Met824, and Gly826. The results of the present 
study show, however, that the role of these positions in the GluN2A 
and GluN2B subunits in determining ethanol sensitivity differs. For 
example, tryptophan mutagenesis at GluN2A(Phe637) increases 
ethanol IC50 by over two-fold relative to the wild-type value (Ren 
et al., 2007), whereas in the GluN2B subunit, tryptophan substitution 
at the cognate position, Phe638, had no effect on ethanol sensitivity. 
Of the four positions in the GluN2B subunit we tested in this study, 
only Phe637 showed alterations in ethanol sensitivity following both 
tryptophan and alanine mutagenesis. We also found no changes in 
glutamate EC50, maximal Iss:Ip, or deactivation time constant in alanine 
or tryptophan substitution mutants at Phe638 or Gly826 (results not 
shown). Interestingly, alanine or tryptophan substitution at Met824 
altered glutamate steady-state EC50 and maximal Iss:Ip values (results 
not shown), as was observed for the cognate position Met823 in 
GluN2A ( Ren et al., 2003a), but did not alter ethanol sensitivity. It 
should be noted, however, that the effect of mutations at 
GluN2A(M823) on ethanol sensitivity is significant, but relatively small, 
so that a subtle difference at this position in the GluN2B could account 
for its lack of regulation of ethanol sensitivity. The tryptophan mutant 
at Phe637 showed increases in both glutamate EC50 and time constant 
of deactivation, and both tryptophan and alanine mutants at this 
position showed decreased macroscopic desensitization. 
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Although the GluN2A and GluN2B subunit share highly 
conserved M domain sequences, our observations demonstrate that 
ethanol's actions on the two subunits differ considerably. Our 
laboratory has reported that two positions in the GluN2A M3 and M4 
domains can functionally interact to regulate ethanol sensitivity (Ren 
et al., 2008), and Smothers and Woodward (2006) identified a pair of 
positions in the GluN1 subunit that can functionally interact with 
respect to ethanol inhibition. Positions at the intersubunit M3-M4 
domain interfaces interact to regulate ethanol sensitivity and ion 
channel function (Ren et al., 2012), and can also form three-way 
interactions with M1 domain residues (Xu et al., 2015). Thus, multiple 
ethanol-sensitive positions appear to form sites of ethanol action. 
Therefore, the differences in ethanol action between GluN2A and 
GluN2B subunits identified in this study may arise because positions in 
the GluN2B subunit interact with other positions in GluN2B or GluN1 in 
a manner that differs from the cognate positions in the GluN2A 
subunit. One possible candidate for such an interacting position is an 
isoleucine at position 571 in the M1-M2 linker of the GluN2A subunit, 
which corresponds to a valine at 572 in the GluN2B subunit (Fig. 9). 
Our energy-minimized models of this region place GluN2A(I571) 
sufficiently close to a substituted tryptophan at 637 to result in a steric 
interaction between these side chains, which may explain the ability of 
the substituted tryptophan to decrease the sensitivity of the receptor 
to ethanol. In contrast, the considerable distance between 
GluN2B(Val572) and position 638 could easily accommodate a 
substituted tryptophan at 638 without steric interaction, so that 
mutations at 638 would not alter ethanol action. An alternative 
possibility is that differences among subunits may arise due to 
regulation of ethanol sensitivity by distant parts of the protein. Many 
studies from this and other laboratories have established that positions 
in the M domains are critically important for the action of ethanol 
(Honse et al., 2004, Ren et al., 2003a, Ren et al., 2003b, Ren et al., 
2007, Ren et al., 2012, Ren et al., 2013, Ronald et al., 2001, 
Smothers and Woodward, 2006, Smothers et al., 2013 and Xu et al., 
2012). For example, a recent study from this laboratory found that 
mutating only two of ten ethanol-sensitive positions in M3 and M4 
could increase the NMDA receptor ethanol IC50 value to over 1 M, 
rendering it insensitive to physiological concentrations of ethanol (Ren 
et al., 2012). However, although the NMDA receptor C-terminal and N-
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terminal domains are not required for the action of ethanol (Peoples 
and Stewart, 2000 and Smothers et al., 2013), both regions can 
influence ethanol sensitivity (Alvestad et al., 2003, Anders et al., 
1999, Anders et al., 2000, Peoples and Stewart, 2000 and Smothers 
et al., 2013), leaving open the possibility that these or other regions 
could contribute to the differences in alcohol action observed in 
GluN2A and GluN2B M domain mutants. 
 
Fig. 9. Tryptophan substitution at a position in M3 differs in the GluN2A and GluN2B 
subunits. Molecular models of the NMDA receptor M domains showing tryptophan 
substitution at 637 in GluN2A (A) or 638 in GluN2B (B). Note the difference in the 
potentially interacting isoleucine 571 in GluN2A vs. valine 572 in GluN2B. The ribbon 
for GluN1 is colored green and for GluN2A/2B is colored red. The proteins are 
superimposed so that the perspective is the same for both. The models were subjected 
to equal amounts of energy minimization. 
Previous studies have found a relation between molecular 
volume of the side chain at sites of alcohol action in GABAA and glycine 
receptors (Kash et al., 2003, Mihic et al., 1997, Wick et al., 
1998 and Yamakura et al., 1999), in the M4 domain of the GluN2A 
subunit (Ren et al., 2003b), and at the cognate position to 
GluN2B(Phe637) in the M3 domain of the NMDA receptor GluN1 
subunit (Smothers and Woodward, 2006) and GluN2A subunit (Ren 
et al., 2007). Although substitution mutations at GluN2B(Phe637) 
could significantly alter ethanol sensitivity, ethanol IC50 was not related 
to side chain molecular volume among the GluN2B(Phe637) mutants 
tested. One explanation for this may be that the side chain at 637 may 
not directly project into the interior of the ethanol-sensitive site, but 
may rather form part of the outer boundary of this site. The reason for 
the discrepancy between the role of molecular volume at this position 
in the GluN2A and GluN2B subunits, however, is not clear at present, 
but serves as additional evidence that the sites of alcohol action on the 
two subunit types differ. The results of the present study also did not 
show any relation between ethanol sensitivity and the hydrophilicity of 
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the substituent at GluN2B(Phe637). Although such a relation was 
observed among mutants at GluN2A(Met823), indicating a possible 
role for hydrophobic binding (Ren et al., 2003b), similar relations were 
not observed for other positions (Ren et al., 2007 and Salous et al., 
2009). The lack of a clear role for molecular volume and 
hydrophobicity in the present study was particularly apparent when 
comparing the leucine and isoleucine mutants: there was a striking 
difference in ethanol sensitivity between the two mutants, even though 
they have identical physicochemical characteristics. Thus, 
GluN2B(Phe637) can regulate receptor ethanol sensitivity in a complex 
manner that relies on the interaction between side chains at this 
position and other positions. Further studies will be needed to define 
these interactions. 
All GluN2B(Phe637) mutants tested in this study showed 
decreased peak glutamate EC50 values and increased maximal Iss:Ip 
values, and only three showed decreased steady-state glutamate EC50 
values. Because Phe637 is in the M3 domain, which has an important 
role in NMDA receptor ion channel gating, and is at a considerable 
distance from the ligand binding domain (Low et al., 2003, Sobolevsky 
et al., 2007, Sobolevsky et al., 2009 and Yuan et al., 2005), the 
changes in glutamate EC50 values among mutants at this position 
appear to result from modifications in ion channel gating. Although we 
did not determine direct measures of ion channel gating, such as mean 
open time, in this study, the differences in macroscopic desensitization 
indicate alterations in ion channel gating among the mutants. The 
observed differences in current amplitude among mutants at 
GluN2B(F637) may also result from altered ion channel gating. The 
isoleucine and leucine mutants also differed from each other with 
respect to glutamate EC50, such that isoleucine, but not leucine, 
substitution increased peak and steady-state glutamate EC50. This 
indicates that not only ethanol sensitivity of the NMDA receptor, but 
also ion channel gating, is sensitive to subtle structural alterations in 
the side chain at 637. A previous study showed that tryptophan 
substitution at GluN2A(Met823) significantly altered both glutamate Iss 
EC50 and desensitization (Ren et al., 2003a), and that the changes in 
glutamate steady-state EC50 values among mutants at this position 
were due to agonist trapping in desensitized states. For a series of 
amino acid substitutions at Phe636 in the GluN2A subunit, which is the 
cognate position of GluN2B(Phe637), Iss:Ip values had an inverse 
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relationship with peak glutamate EC50 values, but were not correlated 
with glutamate steady-state EC50 values (Ren et al., 2013). In 
GluN2B(Phe637) mutants, however, glutamate peak and steady-state 
EC50 values were highly correlated, but neither were correlated with 
maximal Iss:Ip values, indicating that agonist potency can be influenced 
by the substituent at this position in a manner that is independent of 
changes in desensitization. The mechanism for this appears to be due 
to changes in ion channel gating, such as increases in mean open 
time, that secondarily affect agonist binding. Thus, although 
GluN2A(Phe636) and GluN2B(Phe637) are cognate positions, and 
mutations at both positions affect ethanol sensitivity in a remarkably 
similar manner, their roles in regulation of ion channel function differ. 
Previous studies in our laboratory showed that ethanol 
sensitivity of the NMDA receptor was inversely correlated with 
glutamate EC50. In these studies, we observed that mutations at 
GluN2A(F636) and GluN2A(F637) that had higher agonist potency 
exhibited lower ethanol sensitivity (Ren et al., 2007 and Ren et al., 
2013). Similar inverse correlations between ethanol sensitivity and 
glutamate peak, steady-state EC50, or apparent desensitization were 
observed in the current study at GluN2B(Phe637). Ethanol can 
influence desensitization in a number of ion channels (Dopico and 
Lovinger, 2009 and Moykkynen et al., 2003). It is possible that 
changes in ethanol sensitivity observed in the present study are 
secondary to alterations of ion channel function in GluN2B subunit-
containing NMDA receptors, but this possibility is not consistent with 
results of previous studies in which ethanol inhibition of NMDA 
receptors did not involve changes in desensitization (Peoples et al., 
1997, Ren et al., 2003b and Woodward, 2000). Furthermore, studies 
in cells expressing GluN1/GluN2A(F636W) NMDA receptors showed 
that ethanol sensitivity was not altered when ethanol was either pre-
applied for 10 s before receptor was activated or when ethanol was 
applied during steady-state current (Ren et al., 2013). In the present 
study, we found that steady-state and peak current inhibition in 
mutants at GluN2B(Phe637) do not differ (results not shown). It thus 
appears most likely that similar factors may influence both ion channel 
kinetics and ethanol sensitivity in parallel. 
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5. Conclusions 
Although the GluN2A and GluN2B subunit M3 and M4 domains 
are highly homologous, substitution mutations at only two of four 
positions tested affect alcohol sensitivity in both subunits. 
Furthermore, as GluN2B(826) is occupied by a glycine in the native 
protein, the side chain at this position is unlikely to participate in 
alcohol inhibition, although the main chain carbonyl group may do so 
(Dwyer, 1999). The characteristics of the remaining position, 
GluN2B(637), were highly analogous to those of its cognate position in 
the GluN2A subunit, suggesting that there are both important 
similarities and differences in the action of ethanol on the GluN2A and 
GluN2B subunits. 
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